Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, offering promising progress throughout numerous medical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, far more trustworthy choice for therapeutic use, significantly